Ergoteles LLC reduced its position in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 59.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,199 shares of the medical research company’s stock after selling 10,467 shares during the period. Ergoteles LLC’s holdings in Agilent Technologies were worth $875,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in the company. Centiva Capital LP acquired a new stake in Agilent Technologies during the 3rd quarter worth approximately $1,008,000. Penserra Capital Management LLC raised its holdings in Agilent Technologies by 432.5% in the 3rd quarter. Penserra Capital Management LLC now owns 1,853 shares of the medical research company’s stock valued at $224,000 after acquiring an additional 1,505 shares in the last quarter. MML Investors Services LLC raised its holdings in Agilent Technologies by 13.7% in the 3rd quarter. MML Investors Services LLC now owns 20,826 shares of the medical research company’s stock valued at $2,531,000 after acquiring an additional 2,511 shares in the last quarter. Nuveen Asset Management LLC raised its holdings in Agilent Technologies by 0.9% in the 3rd quarter. Nuveen Asset Management LLC now owns 1,587,220 shares of the medical research company’s stock valued at $192,926,000 after acquiring an additional 13,764 shares in the last quarter. Finally, Dohj LLC raised its holdings in Agilent Technologies by 7.7% in the 3rd quarter. Dohj LLC now owns 7,098 shares of the medical research company’s stock valued at $863,000 after acquiring an additional 505 shares in the last quarter. 85.51% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Boon Hwee Koh sold 13,000 shares of the business’s stock in a transaction dated Tuesday, December 6th. The stock was sold at an average price of $152.21, for a total value of $1,978,730.00. Following the transaction, the director now directly owns 57,752 shares of the company’s stock, valued at approximately $8,790,431.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, VP Padraig Mcdonnell sold 672 shares of the company’s stock in a transaction that occurred on Tuesday, December 13th. The stock was sold at an average price of $160.00, for a total transaction of $107,520.00. Following the transaction, the vice president now directly owns 15,529 shares of the company’s stock, valued at approximately $2,484,640. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Boon Hwee Koh sold 13,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 6th. The stock was sold at an average price of $152.21, for a total value of $1,978,730.00. Following the transaction, the director now directly owns 57,752 shares in the company, valued at $8,790,431.92. The disclosure for this sale can be found here. Insiders have sold 52,872 shares of company stock valued at $8,181,671 in the last ninety days. 0.31% of the stock is owned by company insiders.
Agilent Technologies Trading Down 1.4 %
Agilent Technologies declared that its board has authorized a share repurchase program on Monday, January 9th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical research company to repurchase up to 4.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its shares are undervalued.
Agilent Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 26th. Stockholders of record on Tuesday, April 4th will be paid a $0.225 dividend. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Monday, April 3rd. Agilent Technologies’s dividend payout ratio is 21.58%.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. UBS Group lifted their price objective on Agilent Technologies from $152.00 to $170.00 and gave the company a “buy” rating in a report on Tuesday, December 20th. Citigroup lifted their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a report on Tuesday, November 22nd. SVB Leerink lifted their price objective on Agilent Technologies from $160.00 to $170.00 and gave the company an “outperform” rating in a report on Friday, January 6th. Cowen boosted their price objective on Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday, November 22nd. Finally, Jefferies Financial Group boosted their price objective on Agilent Technologies from $158.00 to $168.00 in a research report on Tuesday, November 22nd. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $162.62.
About Agilent Technologies
Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.
Featured Stories
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- MarketBeat Week in Review – 2/20 – 2/24
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
